Stimulation of MMP-1 and CCL2 by NAMPT in PDL cells

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Nokhbehsaim, Marjan ^a   Eick, Sigrun ^b   Nogueira, Andressa Vilas Boas ^a,c   Hoffmann, Per ^a,d   Herms, Stefan ^a,d   Fröhlich, Holger ^a   Jepsen, Søren ^a   Jäger, Andreas ^a   Cirelli, Joni Augusto ^c   Deschner, James ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; INOSITOL TRISPHOSPHATE 3 KINASE; INSULIN LIKE GROWTH FACTOR 2 MRNA BINDING PROTEIN 3; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPILIN 1; NEUROTRIMIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PEPTIDES AND PROTEINS; POTASSIUM CHANNEL TETRAMERIZATION DOMAIN CONTAINING PROTEIN 12; RGS4 PROTEIN; SYNAPTOTAGMIN; SYNAPTOTAGMIN 7; TRANSMEMBRANE 4 L SIX FAMILY MEMBER 20; UNCLASSIFIED DRUG; ADIPOCYTOKINE; CCL2 PROTEIN, HUMAN; MMP1 PROTEIN, HUMAN;

ARTICLE; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROARRAY ANALYSIS; OBESITY; PERIODONTAL LIGAMENT; PERIODONTAL LIGAMENT CELL; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; UPREGULATION; CELL CULTURE; CYTOLOGY; DNA MICROARRAY; GENE EXPRESSION REGULATION; INFLAMMATION; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADIPOKINES; CELLS, CULTURED; CHEMOKINE CCL2; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERIODONTAL LIGAMENT; PERIODONTITIS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84884277332     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/437123     Document Type: Article

References (69)

1. Pihlstrom B. L., Michalowicz B. S., Johnson N. W., Periodontal diseases. The Lancet 2005 366 9499 1809 1820 2-s2.0-27844502483 10.1016/S0140-6736(05) 67728-8
2. Sbordone L., Bortolaia C., Oral microbial biofilms and plaque-related diseases: microbial communities and their role in the shift from oral health to disease. Clinical Oral Investigations 2003 7 4 181 188 2-s2.0-1542675244
3. Albandar J. M., Commentary: underestimation of periodontitis in nhanes surveys. Journal of Periodontology 2011 82 3 337 341 2-s2.0-79952800969 10.1902/jop.2011.100638
4. Beikler T., Flemmig T. F., Oral biofilm-associated diseases: trends and implications for quality of life, systemic health and expenditures. Periodontology 2000 2011 55 1 87 103 2-s2.0-78650062475 10.1111/j.1600-0757. 2010.00360.x
5. Suvan J., D'Aiuto F., Moles D. R., Petrie A., Donos N., Association between overweight/obesity and periodontitis in adults. A systematic review. Obesity Reviews 2011 12 501 e381 e404 2-s2.0-79955045004 10.1111/j.1467-789X. 2010.00808.x
6. Seymour G. J., Ford P. J., Cullinan M. P., Leishman S., Yamazaki K., Relationship between periodontal infections and systemic disease. Clinical Microbiology and Infection 2007 13 4 3 10 2-s2.0-34548178577 10.1111/j.1469-0691.2007.01798.x
7. Conde J., Scotece M., Gómez R., López V., Gómez-Reino J. J., Lago F., Gualillo O., Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. BioFactors 2011 37 6 413 420 2-s2.0-84155163931 10.1002/biof.185
8. Moschen A. R., Gerner R. R., Tilg H., Pre-b cell colony enhancing factor/nampt/visfatin in inflammation and obesityrelated disorders. Current Pharmaceutical Design 2010 16 17 1913 1920 2-s2.0-77953530684 10.2174/138161210791208947
9. Chang Y.-H., Chang D.-M., Lin K.-C., Shin S.-J., Lee Y.-J., Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Diabetes/Metabolism Research and Reviews 2011 27 6 515 527 2-s2.0-80052583612 10.1002/dmrr.1201
10. Taskesen D., Kirel B., Us T., Serum visfatin levels, adiposity and glucose metabolism in obese adolescents. Journal of Clinical Research in Pediatric Endocrinology 2012 4 76 81
11. Zhang L. Q., Heruth D. P., Ye S. Q., Nicotinamide phosphoribosyltransferase in human diseases. Journal of Bioanalysis and Biomedicine 2011 3 1 13 25 2-s2.0-79951968731 10.4172/1948-593X.1000038
12. Pradeep A. R., Raghavendra N.M. R. N. M., Prasad M. V. R., Kathariya R., Patel S. P., Sharma A., Gingival crevicular fluid and serum visfatin concentration: their relationship in periodontal health and disease. Journal of Periodontology 2011 82 9 1314 1319 2-s2.0-80053025084 10.1902/jop.2011.100690
13. Pradeep A. R., Raghavendra N. M., Sharma A., Patel S. P., Raju A., Kathariya R., Rao N. S., Naik S. B., Association of serum and crevicular visfatin levels in periodontal health and disease with type 2 diabetes mellitus. Journal of Periodontology 2012 83 5 629 634 2-s2.0-84860495682 10.1902/jop.2011.110272
14. Nokhbehsaim M., Deschner B., Winter J., Bourauel C., Rath B., Jäger A., Jepsen S., Deschner J., Interactions of regenerative, inflammatory and biomechanical signals on bone morphogenetic protein-2 in periodontal ligament cells. Journal of Periodontal Research 2011 46 3 374 381 2-s2.0-79954596955 10.1111/j.1600-0765.2011.01357.x
15. Nokhbehsaim M., Winter J., Rath B., Jäger A., Jepsen S., Deschner J., Effects of enamel matrix derivative on periodontal wound healing in an inflammatory environment in vitro. Journal of Clinical Periodontology 2011 38 5 479 490 2-s2.0-79954631373 10.1111/j.1600-051X.2010.01696.x
16. Nokhbehsaim M., Deschner B., Winter J., Bourauel C., Jäger A., Jepsen S., Deschner J., Anti-inflammatory effects of EMD in the presence of biomechanical loading and interleukin-1 β in vitro. Clinical Oral Investigations 2012 16 1 275 283 2-s2.0-84855927374 10.1007/s00784-010-0505-8
17. Lin S. M., Du P., Huber W., Kibbe W. A., Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Research 2008 36 2, article e11 2-s2.0-39149111937 10.1093/nar/gkm1075
18. Bolstad B. M., Irizarry R. A., Åstrand M., Speed T. P., A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003 19 2 185 193 2-s2.0-0037316303 10.1093/bioinformatics/19.2.185
19. Du P., Kibbe W. A., Lin S. M., lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008 24 13 1547 1548 2-s2.0-46249088370 10.1093/bioinformatics/btn224
20. Leek J. T., Storey J. D., A general framework for multiple testing dependence. Proceedings of the National Academy of Sciences of the United States of America 2008 105 48 18718 18723 2-s2.0-57749084635 10.1073/pnas.0808709105
21. Smyth G. K., Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology 2004 3 1, article 3 2-s2.0-4544341015
22. Ritchie M. E., Diyagama D., Neilson J., van Laar R., Dobrovic A., Holloway A., Smyth G. K., Empirical array quality weights in the analysis of microarray data. BMC Bioinformatics 2006 7, article 261 2-s2.0-33748865331 10.1186/1471-2105-7-261
23. Benjamini Y., Hochberg Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society B 1995 57 89 300
24. Smyth G. K., Gentleman R., Carey V., Huber W., Irizarry R., Dudoit S., Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions Using R and Bioconductor 2005 New York, NY, USA Springer 397 420
25. Arakaki P. A., Marques M. R., Santos M. C. L. G., MMP-1 polymorphism and its relationship to pathological processes. Journal of Biosciences 2009 34 2 313 320 2-s2.0-69249174673 10.1007/s12038-009-0035-1
26. Ejeil A.-L., Igondjo-Tchen S., Ghomrasseni S., Pellat B., Godeau G., Gogly B., Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva. Journal of Periodontology 2003 74 2 188 195 2-s2.0-0037295912 10.1902/jop.2003.74.2.188
27. Tüter G., Kurtiş B., Serdar M., Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1. Journal of Periodontology 2002 73 5 487 493 2-s2.0-0036107650 10.1902/jop.2002.73.5.487
28. Deshmane S. L., Kremlev S., Amini S., Sawaya B. E., Monocyte chemoattractant protein-1 (MCP-1): an overview. Journal of Interferon and Cytokine Research 2009 29 6 313 326 2-s2.0-66149172257 10.1089/jir.2008.0027
29. Garlet G. P., Martins W. Jr., Ferreira B. R., Milanezi C. M., Silva J. S., Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. Journal of Periodontal Research 2003 38 2 210 217 2-s2.0-0038283165 10.1034/j.1600-0765.2003.02012.x
30. Gupta M., Chaturvedi R., Jain A., Role of monocyte chemoattractant protein-1 (MCP-1) as an immune-diagnostic biomarker in the pathogenesis of chronic periodontal disease. Cytokine 2013 61 892 897
31. Kurtiş B., Tüter G., Serdar M., Akdemir P., Uygur C., Firatli E., Bal B., Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. Journal of Periodontology 2005 76 11 1849 1855 2-s2.0-28644448792 10.1902/jop.2005.76.11.1849
32. Brentano F., Schorr O., Ospelt C., Stanczyk J., Gay R. E., Gay S., Kyburz D., Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis and Rheumatism 2007 56 9 2829 2839 2-s2.0-34848847894 10.1002/art.22833
33. Liu S. W., Qiao S. B., Yuan J. S., Liu D. Q., Visfatin stimulates production of monocyte chemotactic protein-1 and interleukin-6 in human vein umbilical endothelial cells. Hormone and Metabolic Research 2009 41 4 281 286 2-s2.0-65649107670 10.1055/s-0028-1102914
34. Sommer G., Kralisch S., Kloting N., Kamprad M., Schrock K., Kratzsch J., Tonjes A., Lossner U., Bluher M., Stumvoll M., Fasshauer M., Visfatin is a positive regulator of MCP-1 in human adipocytes in vitro and in mice in vivo. Obesity 2010 18 8 1486 1492 2-s2.0-77955050794 10.1038/oby.2009.462
35. Adamson E. D., Mercola D., Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival. Tumor Biology 2002 23 2 93 102 2-s2.0-0036270508 10.1159/000059711
36. Baron V., Adamson E. D., Calogero A., Ragona G., Mercola D., The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGF β 1, PTEN, p53, and fibronectin. Cancer Gene Therapy 2006 13 2 115 124 2-s2.0-30944446390 10.1038/sj.cgt.7700896
37. Ten V. S., Pinsky D. J., Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Current Opinion in Critical Care 2002 8 3 242 250 2-s2.0-0036014523 10.1097/00075198-200206000-00008
38. McMahon S. B., Monroe J. G., The role of early growth response gene 1 (egr-1) in regulation of the immune response. Journal of Leukocyte Biology 1996 60 2 159 166 2-s2.0-0029759909
39. Teitelbaum S. L., The osteoclast and its unique cytoskeleton. Annals of the New York Academy of Sciences 2011 1240 1 14 17 2-s2.0-83755225707 10.1111/j.1749-6632.2011.06283.x
40. Colvin R. A., Means T. K., Diefenbach T. J., Moita L. F., Friday R. P., Sever S., Campanella G. S. V., Abrazinski T., Manice L. A., Moita C., Andrews N. W., Wu D., Hacohen N., Luster A. D., Synaptotagmin-mediated vesicle fusion regulates cell migration. Nature Immunology 2010 11 6 495 502 2-s2.0-77952575435 10.1038/ni.1878
41. Fowler K. T., Andrews N. W., Huleatt J. W., Expression and function of synaptotagmin VII in CTLs. Journal of Immunology 2007 178 3 1498 1504 2-s2.0-33846498689
42. Glavan G., Schliebs R., Živin M., Synaptotagmins in neurodegeneration. Anatomical Record 2009 292 12 1849 1862 2-s2.0-73849122117 10.1002/ar.21026
43. Kato H., Uzawa K., Onda T., Kato Y., Saito K., Nakashima D., Ogawara K., Bukawa H., Yokoe H., Tanzawa H., Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma. International Journal of Oncology 2006 28 4 873 881 2-s2.0-33744734334
44. Windhorst S., Fliegert R., Blechner C., Möllmann K., Hosseini Z., Günther T., Eiben M., Chang L., Lin H.-Y., Fanick W., Schumacher U., Brandt B., Mayr G. W., Inositol 1,4,5-trisphosphate 3-kinase-A is a new cell motility-promoting protein that increases the metastatic potential of tumor cells by two functional activities. Journal of Biological Chemistry 2010 285 8 5541 5554 2-s2.0-77949316749 10.1074/jbc.M109.047050
45. Il H. K., Soon K. P., Soon T. H., Yong S. J., Eun J. K., Eun H. P., Seung B. H., Shin H.-S., Sun W., Hyun T. K., Soderling S. H., Kim H., Inositol 1,4,5-trisphosphate 3-kinase A functions as a scaffold for synaptic rac signaling. Journal of Neuroscience 2009 29 44 14039 14049 2-s2.0-70449435297 10.1523/JNEUROSCI.2483-09.2009
46. Krizsan-Agbas D., Pedchenko T., Smith P. G., Neurotrimin is an estrogen-regulated determinant of peripheral sympathetic innervation. Journal of Neuroscience Research 2008 86 14 3086 3095 2-s2.0-57049133453 10.1002/jnr.21768
47. Chen S., Gil O., Ren Y. Q., Zanazzi G., Salzer J. L., Hillman D. E., Neurotrimin expression during cerebellar development suggests roles in axon fasciculation and synaptogenesis. Journal of Neurocytology 2002 30 11 927 937 2-s2.0-0036851852 10.1023/A:1020673318536
48. Bell J. L., Wächter K., Mühleck B., Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Cellular and Molecular Life Sciences 2013 70 15 2657 2675 10.1007/s00018-012-1186-z
49. Suvasini R., Shruti B., Thota B., Shinde S. V., Friedmann-Morvinski D., Nawaz Z., Prasanna K. V., Thennarasu K., Hegde A. S., Arivazhagan A., Chandramouli B. A., Santosh V., Somasundaram K., Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2. Journal of Biological Chemistry 2011 286 29 25882 25890 2-s2.0-79960433425 10.1074/jbc.M110.178012
50. Staton C. A., Kumar I., Reed M. W. R., Brown N. J., Neuropilins in physiological and pathological angiogenesis. Journal of Pathology 2007 212 3 237 248 2-s2.0-34347332447 10.1002/path.2182
51. Wild J. R. L., Staton C. A., Chapple K., Corfe B. M., Neuropilins: expression and roles in the epithelium. International Journal of Experimental Pathology 2012 93 2 81 103 2-s2.0-84858256282 10.1111/j.1365-2613.2012.00810.x
52. Zachary I. C., How neuropilin-1 regulates receptor tyrosine kinase signalling: the knowns and known unknowns. Biochemical Society Transactions 2011 39 6 1583 1591 2-s2.0-81855169496 10.1042/BST20110697
53. Mizui M., Kikutani H., Neuropilin-1: the glue between regulatory T cells and dendritic cells? Immunity 2008 28 3 302 303 2-s2.0-40249098629 10.1016/j.immuni.2008.02.012
54. Schwenk J., Metz M., Zolles G., Turecek R., Fritzius T., Bildl W., Tarusawa E., Kulik A., Unger A., Ivankova K., Seddik R., Tiao J. Y., Rajalu M., Trojanova J., Rohde V., Gassmann M., Schulte U., Fakler B., Bettler B., Native GABAB receptors are heteromultimers with a family of auxiliary subunits. Nature 2010 465 7295 231 235 2-s2.0-77952422366 10.1038/nature08964
55. Adya R., Tan B. K., Chen J., Randeva H. S., Nuclear factor- b induction by visfatin in human vascular endothelial cells. Diabetes Care 2008 31 4 758 760 2-s2.0-48649109765 10.2337/dc07-1544
56. Fan Y., Meng S., Wang Y., Cao J., Wang C., Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF- B signaling pathway. International Journal of Molecular Medicine 2011 27 4 607 615 2-s2.0-79952209017 10.3892/ijmm.2011.621
57. Nogueira A. V., Nokhbehsaim M., Eick S., Regulation of visfatin by microbial and biomechanical signals in PDL cells. Clinical Oral Investigations. In press
58. Gosset M., Berenbaum F., Salvat C., Sautet A., Pigenet A., Tahiri K., Jacques C., Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. Arthritis and Rheumatism 2008 58 5 1399 1409 2-s2.0-43949131087 10.1002/art.23431
59. Kendal C. E., Bryant-Greenwood G. D., Pre-B-cell colony-enhancing factor (PBEF/Visfatin) gene expression is modulated by NF- B and AP-1 in human amniotic epithelial cells. Placenta 2007 28 4 305 314 2-s2.0-33947721488 10.1016/j.placenta.2006.03.011
60. Williams M. R., Kataoka N., Sakurai Y., Powers C. M., Eskin S. G., McIntire L. V., Gene expression of endothelial cells due to interleukin-1 beta stimulation and neutrophil transmigration. Endothelium 2008 15 1-2 73 84 2-s2.0-46049101617 10.1080/10623320802092443
61. Murakami Y., Kawata A., Seki Y., Comparative inhibitory effects of magnolol, honokiol, eugenol and bis-eugenol on cyclooxygenase-2 expression and nuclear factor-kappa B activation in RAW264. 7 macrophage-like cells stimulated with fimbriae of Porphyromonas gingivalis. In Vivo 2012 26 941 950
62. Reddi D., Brown S. J., Belibasakis G. N., Porphyromonas gingivalis induces RANKL in bone marrow stromal cells: involvement of the p38 MAPK. Microbial Pathogenesis 2011 51 6 415 420 2-s2.0-80054841442 10.1016/j.micpath. 2011.09.001
63. Dunne A., O'Neill L. A. J., The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Science"s STKE 2003 2003 171, article re3 2-s2.0-0037465251
64. Lee J.-K., Kim S.-H., Lewis E. C., Azam T., Reznikov L. L., Dinarello C. A., Differences in signaling pathways by IL-1 β and IL-18. Proceedings of the National Academy of Sciences of the United States of America 2004 101 23 8815 8820 2-s2.0-2942588523 10.1073/pnas.0402800101
65. Holt S. C., Ebersole J. L., Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the "red complex" a prototype polybacterial pathogenic consortium in periodontitis. Periodontology 2000 2005 38 72 122 2-s2.0-20444471123 10.1111/j.1600-0757.2005.00113.x
66. Nakayama K., Molecular genetics of Porphyromonas gingivalis: gingipains and other virulence factors. Current Protein and Peptide Science 2003 4 6 389 395 2-s2.0-0345687940 10.2174/1389203033486983
67. Potempa J., Sroka A., Imamura T., Travis J., Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes. Current Protein and Peptide Science 2003 4 6 397 407 2-s2.0-0344825092 10.2174/1389203033487036
68. Chang Y.-C., Huang F.-M., Yang S.-F., Liu C.-M., Lai C.-C., Chan Y., Hsieh Y.-S., Induction of cyclooxygenase-2 mRNA and protein expression in human pulp cells stimulated with black-pigmented bacteroides. Journal of Endodontics 2003 29 4 240 243 2-s2.0-0037968478 10.1097/00004770-200304000-00002
69. Hayashi Y., Kobayashi M., Kuwata H., Atsumi G.-I., Deguchi K., Feng Wei X., Kudo I., Hasegawa K., Interferon- γ and interleukin 4 inhibit interleukin 1 β -induced delayed prostagilandin E2 generation through suppression of cyclooxugenase-2 expression in human fibroblasts. Cytokine 2000 12 6 603 612 2-s2.0-0033923351 10.1006/cyto.1999.0622